Pregnancy prophylaxis: parenteral postcoital estrogen

Area of Science:

• Reproductive Health
• Pharmacology

Background:

• Emergency contraception is crucial for preventing unintended pregnancies.
• Conjugated estrogen has been explored for postcoital interception.

Purpose of the Study:

• To evaluate the efficacy and safety of a two-dose intravenous conjugated estrogen regimen as postcoital contraception in women following involuntary intercourse.

Main Methods:

• Retrospective study of 118 women treated with two doses of 50 mg intravenous conjugated estrogen, 24 hours apart.
• Follow-up assessment at 30 days or more to determine pregnancy rates.

Main Results:

• Three pregnancies occurred among 92 women with follow-up, all reporting additional unprotected intercourse.
• Side effects were uncommon.
• Intravenous conjugated estrogen was deemed acceptable for post-rape management when no other unprotected intercourse occurred.

Conclusions:

• Intravenous conjugated estrogen can be an acceptable and effective emergency contraceptive option in specific clinical scenarios.
• Further research may be warranted to confirm efficacy in broader populations.